

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * epoxygenase P450 pathway (GO:0019373) | 6.43214181 |
| 2 | angiotensin maturation (GO:0002003) | 6.28422121 |
| 3 | exogenous drug catabolic process (GO:0042738) | 6.22815586 |
| 4 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.03578771 |
| 5 | drug catabolic process (GO:0042737) | 6.00496214 |
| 6 | ethanol oxidation (GO:0006069) | 5.71829975 |
| 7 | intestinal absorption (GO:0050892) | 5.66906861 |
| 8 | cellular glucuronidation (GO:0052695) | 5.50117712 |
| 9 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.44493077 |
| 10 | glucuronate metabolic process (GO:0019585) | 5.29069790 |
| 11 | uronic acid metabolic process (GO:0006063) | 5.29069790 |
| 12 | * drug metabolic process (GO:0017144) | 5.13903855 |
| 13 | urea metabolic process (GO:0019627) | 5.10849444 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 5.02050994 |
| 15 | NADH metabolic process (GO:0006734) | 4.89954190 |
| 16 | plasma lipoprotein particle assembly (GO:0034377) | 4.83649950 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 4.83181245 |
| 18 | bile acid and bile salt transport (GO:0015721) | 4.78815908 |
| 19 | urea cycle (GO:0000050) | 4.78121064 |
| 20 | ethanol metabolic process (GO:0006067) | 4.67079832 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 4.66784539 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.57663110 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.54737054 |
| 24 | phospholipid efflux (GO:0033700) | 4.54690260 |
| 25 | flavonoid metabolic process (GO:0009812) | 4.53189427 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.51737903 |
| 27 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.50585360 |
| 28 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.50585360 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.47621400 |
| 30 | diacylglycerol metabolic process (GO:0046339) | 4.45875112 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.44254810 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.42350959 |
| 33 | hormone catabolic process (GO:0042447) | 4.41543790 |
| 34 | fructose metabolic process (GO:0006000) | 4.37537968 |
| 35 | regulation of guanylate cyclase activity (GO:0031282) | 4.33648128 |
| 36 | protein-lipid complex assembly (GO:0065005) | 4.32311592 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.31804470 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.31804470 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.31804470 |
| 40 | regulation of complement activation (GO:0030449) | 4.29729118 |
| 41 | lipoprotein transport (GO:0042953) | 4.27298446 |
| 42 | bile acid metabolic process (GO:0008206) | 4.21800177 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.18888596 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 4.17267885 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.08136901 |
| 46 | cholesterol efflux (GO:0033344) | 4.01508072 |
| 47 | alkaloid metabolic process (GO:0009820) | 4.00446992 |
| 48 | plasma lipoprotein particle organization (GO:0071827) | 3.95746350 |
| 49 | negative regulation of sterol transport (GO:0032372) | 3.88373801 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 3.88373801 |
| 51 | lipoprotein metabolic process (GO:0042157) | 3.86785902 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82468670 |
| 53 | L-phenylalanine catabolic process (GO:0006559) | 3.82468670 |
| 54 | * fat-soluble vitamin biosynthetic process (GO:0042362) | 3.77833215 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.76581446 |
| 56 | positive regulation of lipid catabolic process (GO:0050996) | 3.74892244 |
| 57 | protein-lipid complex subunit organization (GO:0071825) | 3.73071100 |
| 58 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.72364780 |
| 59 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.72364780 |
| 60 | endocrine process (GO:0050886) | 3.72364780 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.71564033 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 3.71564033 |
| 63 | regulation of cholesterol homeostasis (GO:2000188) | 3.66859900 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66549433 |
| 65 | protein carboxylation (GO:0018214) | 3.66549433 |
| 66 | complement activation, classical pathway (GO:0006958) | 3.64619212 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.59391074 |
| 68 | phenylpropanoid metabolic process (GO:0009698) | 3.57834859 |
| 69 | arginine metabolic process (GO:0006525) | 3.54269717 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53611768 |
| 71 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.47943463 |
| 72 | glyoxylate metabolic process (GO:0046487) | 3.45182775 |
| 73 | drug transport (GO:0015893) | 3.40101643 |
| 74 | vitamin transmembrane transport (GO:0035461) | 3.38946439 |
| 75 | drug transmembrane transport (GO:0006855) | 3.38727959 |
| 76 | protein activation cascade (GO:0072376) | 3.38531473 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.35740941 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.35740941 |
| 79 | complement activation (GO:0006956) | 3.32223459 |
| 80 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.32090784 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.29577567 |
| 82 | fibrinolysis (GO:0042730) | 3.26947928 |
| 83 | proline metabolic process (GO:0006560) | 3.25069825 |
| 84 | sterol homeostasis (GO:0055092) | 3.23766494 |
| 85 | regulation of systemic arterial blood pressure (GO:0003073) | 3.22858979 |
| 86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.17283413 |
| 87 | acute-phase response (GO:0006953) | 3.16945721 |
| 88 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.15501654 |
| 89 | primary alcohol catabolic process (GO:0034310) | 3.15492113 |
| 90 | regulation of cholesterol metabolic process (GO:0090181) | 3.12329971 |
| 91 | * negative regulation of blood coagulation (GO:0030195) | 3.06433725 |
| 92 | * negative regulation of hemostasis (GO:1900047) | 3.06433725 |
| 93 | primary alcohol metabolic process (GO:0034308) | 3.05094255 |
| 94 | oxidative demethylation (GO:0070989) | 3.02363309 |
| 95 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.01088465 |
| 96 | bile acid biosynthetic process (GO:0006699) | 2.97888089 |
| 97 | oxaloacetate metabolic process (GO:0006107) | 2.96688182 |
| 98 | glutamate metabolic process (GO:0006536) | 2.94979699 |
| 99 | * xenobiotic metabolic process (GO:0006805) | 2.90574651 |
| 100 | peptide catabolic process (GO:0043171) | 2.90455914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.75761083 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47274445 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00857675 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77822820 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.69091989 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.66424594 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.63947193 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.29453131 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86248739 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.66639254 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.39201304 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.33056151 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.28707033 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26463406 |
| 15 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.22704822 |
| 16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.04725758 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.96959819 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94914794 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88929577 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.87722744 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81655161 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78852276 |
| 23 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.78797036 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69033377 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68497681 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.67777438 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62381596 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62317210 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.57682143 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54520865 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.45298254 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44903439 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44063217 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40090453 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38891107 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38730899 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37698594 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37443778 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36218181 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31644371 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28585475 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22423893 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22134255 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20513413 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20034775 |
| 46 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19851614 |
| 47 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16676964 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16069534 |
| 49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12482137 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11507233 |
| 51 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.10606817 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09229299 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07375957 |
| 54 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04688833 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04259932 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01818838 |
| 57 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01425489 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00828303 |
| 59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98835899 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96611644 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96236227 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95316042 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94986244 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93128623 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91359942 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89802999 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.89747584 |
| 68 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89560432 |
| 69 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89516856 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88726136 |
| 71 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88724205 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88418449 |
| 73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88373468 |
| 74 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87482749 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87423749 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86925463 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86223578 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85647791 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84077935 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81980819 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81379471 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79200134 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79038515 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.78760752 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78500950 |
| 86 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78388165 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78166826 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76607893 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75785360 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75562694 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75467401 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75411780 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.75328825 |
| 94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74040336 |
| 95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73901810 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73366971 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73073616 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71929161 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71908372 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.70756057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.96221073 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.24859613 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.28429553 |
| 4 | MP0005365_abnormal_bile_salt | 4.89088589 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.44187978 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11009231 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.00238067 |
| 8 | MP0009840_abnormal_foam_cell | 2.95616784 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.84886026 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.78601783 |
| 11 | MP0003252_abnormal_bile_duct | 2.68001873 |
| 12 | MP0003868_abnormal_feces_composition | 2.45034362 |
| 13 | MP0003195_calcinosis | 2.40342749 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.38540997 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.25224403 |
| 16 | MP0005332_abnormal_amino_acid | 2.17583635 |
| 17 | MP0005670_abnormal_white_adipose | 1.93203354 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93106097 |
| 19 | MP0010155_abnormal_intestine_physiology | 1.88181075 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.82216748 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.71819717 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.71575285 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.70794539 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.63723452 |
| 25 | MP0000609_abnormal_liver_physiology | 1.61709618 |
| 26 | MP0005409_darkened_coat_color | 1.59908193 |
| 27 | MP0004147_increased_porphyrin_level | 1.54584275 |
| 28 | MP0001764_abnormal_homeostasis | 1.50994700 |
| 29 | MP0003866_abnormal_defecation | 1.50184826 |
| 30 | MP0005451_abnormal_body_composition | 1.50140690 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.45526843 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.35770755 |
| 33 | MP0001664_abnormal_digestion | 1.32642163 |
| 34 | MP0004043_abnormal_pH_regulation | 1.30809773 |
| 35 | MP0000566_synostosis | 1.21776963 |
| 36 | MP0002971_abnormal_brown_adipose | 1.20871874 |
| 37 | MP0003879_abnormal_hair_cell | 1.20270966 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.18743145 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.13990406 |
| 40 | MP0005166_decreased_susceptibility_to | 1.12456945 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05402180 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.04882198 |
| 43 | MP0002136_abnormal_kidney_physiology | 1.02096545 |
| 44 | MP0001756_abnormal_urination | 0.99158343 |
| 45 | MP0000477_abnormal_intestine_morphology | 0.98156781 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 0.93279057 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 0.93187255 |
| 48 | MP0005448_abnormal_energy_balance | 0.92251742 |
| 49 | MP0002796_impaired_skin_barrier | 0.91047692 |
| 50 | MP0009642_abnormal_blood_homeostasis | 0.90407912 |
| 51 | MP0001663_abnormal_digestive_system | 0.89129850 |
| 52 | MP0002132_abnormal_respiratory_system | 0.88494033 |
| 53 | MP0008469_abnormal_protein_level | 0.87587895 |
| 54 | MP0005058_abnormal_lysosome_morphology | 0.87025223 |
| 55 | MP0005666_abnormal_adipose_tissue | 0.83388458 |
| 56 | MP0005535_abnormal_body_temperature | 0.83001855 |
| 57 | MP0009115_abnormal_fat_cell | 0.82627683 |
| 58 | MP0003724_increased_susceptibility_to | 0.80528809 |
| 59 | MP0000490_abnormal_crypts_of | 0.77984471 |
| 60 | MP0009785_altered_susceptibility_to | 0.77007723 |
| 61 | MP0000538_abnormal_urinary_bladder | 0.75764307 |
| 62 | MP0003436_decreased_susceptibility_to | 0.72333627 |
| 63 | MP0001873_stomach_inflammation | 0.71322759 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.70097859 |
| 65 | MP0002166_altered_tumor_susceptibility | 0.68889607 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.68546293 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 0.68361436 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 0.68025018 |
| 69 | MP0000598_abnormal_liver_morphology | 0.67954907 |
| 70 | MP0008872_abnormal_physiological_respon | 0.67345208 |
| 71 | MP0005408_hypopigmentation | 0.65652136 |
| 72 | MP0004858_abnormal_nervous_system | 0.65425687 |
| 73 | MP0000249_abnormal_blood_vessel | 0.64642735 |
| 74 | MP0005334_abnormal_fat_pad | 0.62857440 |
| 75 | MP0000604_amyloidosis | 0.62476488 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.60161223 |
| 77 | MP0005025_abnormal_response_to | 0.59135254 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.58852919 |
| 79 | MP0003303_peritoneal_inflammation | 0.58183352 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 0.57659604 |
| 81 | MP0009764_decreased_sensitivity_to | 0.56825421 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.55305631 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.54965665 |
| 84 | MP0003953_abnormal_hormone_level | 0.53378162 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.52416557 |
| 86 | MP0009763_increased_sensitivity_to | 0.51786641 |
| 87 | MP0003718_maternal_effect | 0.50413629 |
| 88 | MP0005501_abnormal_skin_physiology | 0.49167865 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.48652390 |
| 90 | MP0002822_catalepsy | 0.48538448 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.47430526 |
| 92 | MP0000462_abnormal_digestive_system | 0.46904589 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.46895085 |
| 94 | MP0004947_skin_inflammation | 0.45681792 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.45474807 |
| 96 | MP0009697_abnormal_copulation | 0.44994022 |
| 97 | MP0003075_altered_response_to | 0.44118658 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.41399312 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.41383468 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.40394880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.45101408 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.70581901 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.49099860 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.79264597 |
| 5 | Complement deficiency (HP:0004431) | 5.70445497 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.60313467 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.16490075 |
| 8 | Hydroxyprolinuria (HP:0003080) | 5.16490075 |
| 9 | Abnormality of complement system (HP:0005339) | 4.84692395 |
| 10 | Malnutrition (HP:0004395) | 4.75501684 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.72650790 |
| 12 | Xanthomatosis (HP:0000991) | 4.66312073 |
| 13 | Fat malabsorption (HP:0002630) | 4.30295828 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24708429 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 4.12567375 |
| 16 | Hemorrhage of the eye (HP:0011885) | 4.08626755 |
| 17 | Glomerulonephritis (HP:0000099) | 4.02230775 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.78737073 |
| 19 | Joint hemorrhage (HP:0005261) | 3.70270857 |
| 20 | Widely patent fontanelles and sutures (HP:0004492) | 3.57340043 |
| 21 | Hyperglycinuria (HP:0003108) | 3.55581277 |
| 22 | Acanthocytosis (HP:0001927) | 3.47551793 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 3.36752389 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35554443 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.35554443 |
| 26 | Ileus (HP:0002595) | 3.22169786 |
| 27 | Abnormality of vitamin metabolism (HP:0100508) | 3.22084802 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 3.19301591 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 3.14211223 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.06354091 |
| 31 | Chronic diarrhea (HP:0002028) | 3.04813110 |
| 32 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.99852876 |
| 33 | Nephritis (HP:0000123) | 2.99267493 |
| 34 | Hyperammonemia (HP:0001987) | 2.92441514 |
| 35 | Decreased circulating renin level (HP:0003351) | 2.91125477 |
| 36 | Steatorrhea (HP:0002570) | 2.89140997 |
| 37 | Alkalosis (HP:0001948) | 2.86565407 |
| 38 | Epidermoid cyst (HP:0200040) | 2.84667269 |
| 39 | Abnormality of vitamin B metabolism (HP:0004340) | 2.84199468 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83189160 |
| 41 | Abnormality of urine glucose concentration (HP:0011016) | 2.81167632 |
| 42 | Glycosuria (HP:0003076) | 2.81167632 |
| 43 | Pigmentary retinal degeneration (HP:0001146) | 2.80685080 |
| 44 | Confusion (HP:0001289) | 2.71692742 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.70353721 |
| 46 | Potter facies (HP:0002009) | 2.65138096 |
| 47 | Facial shape deformation (HP:0011334) | 2.65138096 |
| 48 | Vascular calcification (HP:0004934) | 2.58847324 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54265329 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52522866 |
| 51 | Metabolic alkalosis (HP:0200114) | 2.50849610 |
| 52 | Hypophosphatemia (HP:0002148) | 2.50372031 |
| 53 | Rickets (HP:0002748) | 2.50227342 |
| 54 | Wide cranial sutures (HP:0010537) | 2.47787125 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.47009563 |
| 56 | Flat acetabular roof (HP:0003180) | 2.43110359 |
| 57 | Nausea (HP:0002018) | 2.41084715 |
| 58 | Abdominal distention (HP:0003270) | 2.39416090 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.35451635 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34806303 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.32078168 |
| 62 | Nephrolithiasis (HP:0000787) | 2.29502437 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24935396 |
| 64 | Megaloblastic anemia (HP:0001889) | 2.22268108 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.21030821 |
| 66 | Hypotension (HP:0002615) | 2.20976637 |
| 67 | Spontaneous abortion (HP:0005268) | 2.18950680 |
| 68 | Delayed CNS myelination (HP:0002188) | 2.18448048 |
| 69 | Metabolic acidosis (HP:0001942) | 2.18296846 |
| 70 | Gingival bleeding (HP:0000225) | 2.18000336 |
| 71 | Thin bony cortex (HP:0002753) | 2.17838909 |
| 72 | Poikilocytosis (HP:0004447) | 2.17726681 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.16065833 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 2.12888767 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.12630827 |
| 76 | Increased purine levels (HP:0004368) | 2.09467303 |
| 77 | Hyperuricemia (HP:0002149) | 2.09467303 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.09447456 |
| 79 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07637678 |
| 80 | Cerebral palsy (HP:0100021) | 2.02287516 |
| 81 | Amyloidosis (HP:0011034) | 2.00847086 |
| 82 | Hyperglycinemia (HP:0002154) | 2.00825738 |
| 83 | Hypophosphatemic rickets (HP:0004912) | 2.00670224 |
| 84 | Purpura (HP:0000979) | 1.99452542 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 1.97504072 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96821221 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 1.96635699 |
| 88 | Skin nodule (HP:0200036) | 1.95332532 |
| 89 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90777944 |
| 90 | Hypoalphalipoproteinemia (HP:0003233) | 1.88714887 |
| 91 | Pancreatitis (HP:0001733) | 1.88555683 |
| 92 | Gout (HP:0001997) | 1.87957165 |
| 93 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86559447 |
| 94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81185560 |
| 95 | Irritability (HP:0000737) | 1.80620727 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80344089 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 1.80344089 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 1.79847925 |
| 99 | Glomerulosclerosis (HP:0000096) | 1.78048042 |
| 100 | Hyperbilirubinemia (HP:0002904) | 1.74715314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.00799987 |
| 2 | ERN1 | 4.96688932 |
| 3 | ACVR1B | 4.88597542 |
| 4 | RIPK1 | 3.74631943 |
| 5 | FGFR4 | 3.65578620 |
| 6 | EPHA2 | 3.33830507 |
| 7 | PRKG2 | 2.54893982 |
| 8 | FGFR3 | 2.41653715 |
| 9 | PIK3CA | 2.32849525 |
| 10 | TYK2 | 1.98152300 |
| 11 | MAP3K2 | 1.90427356 |
| 12 | MET | 1.84083060 |
| 13 | PTK6 | 1.71487811 |
| 14 | EPHA3 | 1.66413925 |
| 15 | GRK6 | 1.56071932 |
| 16 | EPHB1 | 1.50508364 |
| 17 | PRKAA2 | 1.33343782 |
| 18 | MAP4K1 | 1.31956227 |
| 19 | LMTK2 | 1.29465340 |
| 20 | TRIB3 | 1.27556415 |
| 21 | STK39 | 1.23222974 |
| 22 | DYRK1B | 1.21980130 |
| 23 | MAP3K1 | 1.21691851 |
| 24 | SIK1 | 1.21407718 |
| 25 | PDPK1 | 1.19288530 |
| 26 | MAP3K3 | 1.17528213 |
| 27 | DDR2 | 1.14963315 |
| 28 | AKT3 | 1.14266270 |
| 29 | ERBB2 | 1.10323240 |
| 30 | MAPK11 | 1.08744756 |
| 31 | MAP3K10 | 1.08705733 |
| 32 | RIPK4 | 1.03318584 |
| 33 | STK24 | 1.01758569 |
| 34 | TAOK1 | 1.00772885 |
| 35 | MATK | 0.97379904 |
| 36 | FER | 0.96709480 |
| 37 | MAP2K6 | 0.95559308 |
| 38 | MAP2K2 | 0.92867698 |
| 39 | NLK | 0.90229125 |
| 40 | CDC42BPA | 0.87475405 |
| 41 | MAP3K12 | 0.86634240 |
| 42 | PDK1 | 0.85550929 |
| 43 | ICK | 0.83951240 |
| 44 | MYLK | 0.80865015 |
| 45 | MAP3K11 | 0.79108689 |
| 46 | PRKACG | 0.78986275 |
| 47 | MAPKAPK3 | 0.77915784 |
| 48 | OXSR1 | 0.77633394 |
| 49 | RET | 0.76964664 |
| 50 | PRPF4B | 0.76228314 |
| 51 | TBK1 | 0.75723007 |
| 52 | PDK2 | 0.72402270 |
| 53 | CSK | 0.71972353 |
| 54 | TESK2 | 0.71970228 |
| 55 | IRAK1 | 0.71032831 |
| 56 | EPHB2 | 0.69739759 |
| 57 | JAK1 | 0.68670416 |
| 58 | ZAP70 | 0.68150001 |
| 59 | PRKCZ | 0.67156930 |
| 60 | PDGFRA | 0.62259089 |
| 61 | EPHA4 | 0.62047224 |
| 62 | MAP3K7 | 0.61519647 |
| 63 | SMG1 | 0.59952067 |
| 64 | WNK4 | 0.59054069 |
| 65 | MAP3K6 | 0.58828367 |
| 66 | MST4 | 0.58384011 |
| 67 | JAK2 | 0.57115944 |
| 68 | TGFBR2 | 0.55075950 |
| 69 | CSF1R | 0.54249458 |
| 70 | FGR | 0.52956108 |
| 71 | YES1 | 0.52934193 |
| 72 | SRC | 0.48652042 |
| 73 | FRK | 0.47058087 |
| 74 | BLK | 0.45577481 |
| 75 | IRAK4 | 0.43866638 |
| 76 | KSR2 | 0.42698781 |
| 77 | IGF1R | 0.42340300 |
| 78 | IKBKE | 0.42215957 |
| 79 | FGFR2 | 0.41572601 |
| 80 | TESK1 | 0.40770258 |
| 81 | PRKCA | 0.39784776 |
| 82 | FYN | 0.38855649 |
| 83 | CDK6 | 0.38108210 |
| 84 | EEF2K | 0.35776671 |
| 85 | PRKAA1 | 0.34537561 |
| 86 | LATS1 | 0.32903473 |
| 87 | PTK2 | 0.32722027 |
| 88 | MAP2K3 | 0.30420793 |
| 89 | FGFR1 | 0.29644569 |
| 90 | JAK3 | 0.29131742 |
| 91 | ABL2 | 0.28395438 |
| 92 | BMX | 0.28036892 |
| 93 | DAPK2 | 0.27622425 |
| 94 | MAPKAPK2 | 0.27306369 |
| 95 | LYN | 0.25873052 |
| 96 | CAMK2D | 0.25767631 |
| 97 | MAP2K4 | 0.25701915 |
| 98 | SYK | 0.24797725 |
| 99 | TNK2 | 0.24592817 |
| 100 | IRAK3 | 0.24212525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.74192835 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.36376605 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18160753 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.10940120 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.89261557 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.83286430 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71188927 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.69872738 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.66746807 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58872602 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.56697334 |
| 12 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.53149263 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.33795387 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28584741 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.28344286 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.22946320 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.15238920 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.13013785 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01347364 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.99441108 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.98752610 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.89971420 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84834628 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84658071 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69863850 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60240664 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.59841759 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58706490 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.57796551 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44711930 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42286829 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.37683384 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30496220 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30271420 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27630692 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26152769 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25075862 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20736044 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19381281 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15782032 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.10056188 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04979358 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01928876 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97572948 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.97395272 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97334024 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95309684 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94485326 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93676831 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92164816 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87109262 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85568212 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.81416158 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77861371 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75984904 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69190613 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67100948 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65604008 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61145791 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58027046 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57663759 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54438390 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51189414 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51116210 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50455658 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49055841 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.47147603 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45391767 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44009328 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42955489 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40661469 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37794679 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33672691 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.32386796 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31226750 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31061851 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.27133444 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.25953567 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25653323 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24153636 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18760704 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.18154421 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.16836898 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15988115 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13538561 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.13488828 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.13178489 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12947002 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12372079 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.10531534 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09824406 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09280976 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.07561991 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.06409121 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05690552 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04815712 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04328416 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.00669982 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | -0.0071506 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | -0.0052885 |

